| Revenue | DKK 499K | -33% |
| EBITDA | DKK 39K | -51% |
| Net profit | DKK 27K | -53% |
| Total assets | DKK 290K | +3% |
| Equity | DKK 229K | +14% |
| Employees | 1 | — |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -6 | -32 | 15 | 111 | 265 | 671 | 196 | 65 | 739 | 499 |
| Staff expenses | -0 | -0 | -0 | -77 | -255 | -607 | -144 | -5 | -660 | -460 |
| EBITDA | -6 | -32 | 15 | 34 | 10 | 63 | 52 | 70 | 79 | 39 |
| Depreciation & amort. | -0 | -19 | -19 | -19 | -19 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -6 | -51 | -4 | 15 | -9 | 63 | 52 | 70 | 79 | 39 |
| Net financials | -1 | -0 | -2 | -6 | -6 | 13 | -3 | -2 | -4 | -4 |
| Profit before tax | -6 | -52 | -6 | 9 | -15 | 77 | 50 | 68 | 75 | 35 |
| Tax | -1 | -11 | -1 | 2 | -3 | 18 | 11 | 15 | 17 | 8 |
| Net profit | -5 | -40 | -5 | 7 | -12 | 58 | 38 | 52 | 58 | 27 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 108 | 118 | 201 | 267 | 441 | 190 | 393 | 309 | 283 | 290 |
| Equity | 45 | 4 | -0 | 7 | -5 | 53 | 91 | 144 | 202 | 229 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 64 | 114 | 201 | 260 | 446 | 136 | 301 | 165 | 81 | 61 |
| Total debt | 64 | 114 | 201 | 260 | 446 | 136 | 301 | 165 | 81 | 61 |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
OØ Management | Management | 2014 | — | — |
HK Management | Management | 2021 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Medivatus Group ApS | Company | 100.0% | 100.0% | 2019 |
| Individual | 100.0% | 100.0% | 2017 |
| Person | Role here | Other companies |
|---|---|---|
| Odd Øyvind Carlsvig | Management | 0 companies |
| Helle Katrine Jørgensen | Management | 0 companies |